We are live on
!
Find out more
SC
SRB Corp Portfolio holdings
AUM
$1.63B
1-Year Est. Return
20.77%
This Fund
S&P 500
This Quarter
Est. Return
+13.78%
1 Year Est. Return
+20.77%
3 Year Est. Return
+53.11%
5 Year Est. Return
+65.5%
10 Year Est. Return
+234.08%
AUM
$1.22B
AUM Growth
+$148M
(+14%)
Cap. Flow
+$17.2M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
93.98%
Holding
183
New
14
Increased
82
Reduced
32
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$17.4M |
| 2 |
CBRE Group
CBRE
|
+$550K |
| 3 |
Vulcan Materials
VMC
|
+$540K |
| 4 |
Martin Marietta Materials
MLM
|
+$539K |
| 5 |
Lamb Weston
LW
|
+$529K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$656K |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$612K |
| 3 |
Walmart Inc
WMT
|
+$509K |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$471K |
| 5 |
Tractor Supply
TSCO
|
+$464K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 49.66% |
| 2 | Healthcare | 23.18% |
| 3 | Financials | 12.53% |
| 4 | Energy | 6.81% |
| 5 | Industrials | 4.07% |
Similar funds
SWA
AIP
GIP
CC
PCM
MAC
TCA
PRA
SRB Corp's Q2 2020 Portfolio in Review
As of Q2 2020, SRB Corp held 183 positions worth $1.22B, up 14% from $1.07B the previous quarter. Its ten largest holdings account for 94% of the portfolio.
SRB Corp's Q2 2020 filing shows 14 new, 82 increased, 32 reduced and 40 closed positions. Its largest new stake was CBRE Group: 12,747 shares worth $576K. The largest sale was Regeneron Pharmaceuticals, an estimated $656K.
By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 47% a quarter earlier, followed by Healthcare and Financials.
- SRB Corp's largest Q2 2020 buy was CBRE Group: 12,747 shares worth $576K.
- SRB Corp added most to Royal Dutch Shell PLC ADS Class B in Q2 2020, an estimated $17.4M increase.
- SRB Corp's biggest Q2 2020 reduction was Newmont, cutting an estimated $272K.
- SRB Corp fully exited Regeneron Pharmaceuticals in Q2 2020, selling an estimated $656K.
- SRB Corp's ten largest holdings make up 94% of its $1.22B portfolio in Q2 2020.
- SRB Corp opened 14 new positions and closed 40 in Q2 2020.
- SRB Corp's portfolio value rose 14% quarter-over-quarter to $1.22B.
Based on SRB Corp's 13F filing for Q2 2020, filed 14 Aug 2020.